Are We Missing the Elephant in the Room? A Case for Thyroid Cancer Overdiagnosis as the Etiology for Its Increasing Incidence in India by Sekkath Veedu, Janeesh & Mathew, Aju
University of Kentucky
UKnowledge
Internal Medicine Faculty Publications Internal Medicine
10-22-2018
Are We Missing the Elephant in the Room? A Case
for Thyroid Cancer Overdiagnosis as the Etiology
for Its Increasing Incidence in India
Janeesh Sekkath Veedu
University of Kentucky, janeesh.veedu@uky.edu
Aju Mathew
University of Kentucky, aju.mathew@uky.edu
Right click to open a feedback form in a new tab to let us know how this document benefits you.
Follow this and additional works at: https://uknowledge.uky.edu/internalmedicine_facpub
Part of the Diagnosis Commons, and the Oncology Commons
This Commentary is brought to you for free and open access by the Internal Medicine at UKnowledge. It has been accepted for inclusion in Internal
Medicine Faculty Publications by an authorized administrator of UKnowledge. For more information, please contact UKnowledge@lsv.uky.edu.
Repository Citation
Sekkath Veedu, Janeesh and Mathew, Aju, "Are We Missing the Elephant in the Room? A Case for Thyroid Cancer Overdiagnosis as
the Etiology for Its Increasing Incidence in India" (2018). Internal Medicine Faculty Publications. 168.
https://uknowledge.uky.edu/internalmedicine_facpub/168
Are We Missing the Elephant in the Room? A Case for Thyroid Cancer Overdiagnosis as the Etiology for Its
Increasing Incidence in India
Notes/Citation Information
Published in Journal of Global Oncology, v. 4, p. 1-3.
© 2018 by American Society of Clinical Oncology
Licensed under the Creative Commons Attribution 4.0 License.
Digital Object Identifier (DOI)
https://doi.org/10.1200/JGO.18.00177
This commentary is available at UKnowledge: https://uknowledge.uky.edu/internalmedicine_facpub/168
Are We Missing the Elephant in the 
Room? A Case for Thyroid Cancer 
Overdiagnosis As the Etiology for Its 
Increasing Incidence in India
The incidence of differentiated thyroid cancers, 
especially the papillary subtype, has been increasing 
worldwide. The SEER database from the United 
States showed a three-fold increase in thyroid 
cancer incidence from 1975 to 2010, with a rel-
atively stable thyroid cancer–specific mortality 
rate.1 Similarly, in South Korea, thyroid cancer 
incidence increased by seven-fold from 1999 to 
2009.2 India is not an exception to this trend.3 
Several regions of India have seen an increase in 
incidence of thyroid cancer.
Women are predominantly affected by this trend.1 
The majority of newly diagnosed thyroid cancers 
are small and of the papillary histologic type.4,5 In 
countries where the incidence is rapidly increas-
ing, the increase has been attributed to a dispro-
portionate increase in diagnosis of small papillary 
thyroid cancers.6 Approximately one sixth of com-
puted tomography scans and magnetic resonance 
images show incidental thyroid nodules, of which 
the majority are smaller nodules.7,8
On the basis of such information, several studies 
from developed regions of the world have con-
cluded that overdiagnosis is the leading cause 
of this astounding increase in the incidence of 
thyroid cancer.9,10 The influence of environmental 
and other risk factors on this increased incidence 
is controversial and, if present, likely marginal. An 
increase in the prevalence of risk factors such as 
obesity and tobacco use could contribute to an 
increased incidence of thyroid cancer. However, 
why are women in India, who have lower rates of 
obesity and smoking, also experiencing an increase 
in thyroid cancer diagnosis?
We recently reported that overdiagnosis could be 
the reason for the doubling of thyroid cancer inci-
dence in the state of Kerala in southern India.3 
In this region, the incidence of thyroid cancer 
is at least four-fold the incidence seen in other 
regions of India. In the population-based cancer 
registry (PBCR) based in the city of Thiruvanan-
thapuram in Kerala, the incidence of thyroid 
cancer doubled over a decade. The age-adjusted 
incidence rate in 2005 to 2008 was 6.9 per 
100,000 women; this rate increased to 13.3 per 
100,000 women in 2012 to 2014. However, the 
mortality rate remained stable. Similar trends in 
thyroid cancer–specific mortality were also noted 
in other PBCRs based in major cities such as 
Delhi, Mumbai, Bangalore, and Chennai. It is 
this mismatch between the increased incidence 
rate and stable mortality rate of thyroid cancer 
that points to the contribution of overdiagnosis.
However, a recent editorial in the Indian Journal 
of Cancer overlooked the putative role of overdi-
agnosis in the increasing incidence rate of thy-
roid cancer in India.11 The editorial suggests that 
the rate of larger thyroid cancers has increased 
in India and that the thyroid cancer–specific 
mortality rate has also increased. To our knowl-
edge, there are no data from India that confirm 
an increase in incidence of larger tumors. The 
PBCRs of India do not report data on tumor 
size or proportion of patients with differentiated 
thyroid cancer diagnosis. In addition, available 
data suggest that the thyroid cancer–specific 
mortality rate is stable in India.
The editorial points to three putative factors 
responsible for the increase in thyroid cancer 
rates. First, there is a link between radiation 
exposure and thyroid cancer. Could the back-
ground radiation from the thorium-rich sand in 
Kerala be contributing to an increase in thyroid 
cancer rates? This is unlikely; exposure to radi-
ation at the level of a nuclear disaster needs to 
occur in the region for incidence rates to increase 
at such a rapid pace. Second, thyroid autoim-
mune diseases may elevate an individual’s risk 
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for differentiated thyroid cancer. However, such 
diseases have not been shown to have increased 
in incidence over time. Third, could an increase 
in iodine exposure through dietary sources be 
elevating the risk for thyroid cancer? Once again, 
this hypothesis remains just another oft-cited 
theory and is unlikely to have contributed to the 
dramatic increase in thyroid cancer rates.
Although all of these putative risk factors can-
not be ignored, they do not explain the dramatic 
increase in incidence of thyroid cancer. Even if 
increasing rates of obesity or tobacco exposure 
result in an elevated risk for thyroid cancer, the 
strength of such an association would have to be 
profound to result in such a significant increase 
in the incidence rate of thyroid cancer. One other 
factor that could possible result in an increase 
the incidence rate is poor quality of diagnosis 
documentation in the registry in the initial years. 
However, even if this was the case, why would 
the incidence in Kerala be four times that seen 
in Delhi, Mumbai, Chennai, or Bangalore? The 
reality of overdiagnosis as the leading cause of 
the increase in incidence of thyroid cancer can-
not be pushed under the rug.
It is important to look at examples from other 
regions that have seen similar trends in increas-
ing incidence of thyroid cancer. The implemen-
tation of a national cancer screening program 
in South Korea led to providers offering thyroid 
screening for a low fee and thus an explosion 
of new thyroid cancers. Thyroid cancer inci-
dence in Korea increased slowly in the 1990s 
and then increased meteorically in 2011 to 15 
times that observed in 1993. Ahn and Welch12 
clearly caution the rest of the world on the basis 
of their experience with thyroid cancer screen-
ing in South Korea. Ignoring this warning and 
underplaying the importance of overdiagnosis 
in India could lead to the same situation as that 
seen in South Korea, especially as diagnostic 
laboratories and imaging modalities increase in 
India. In South Korea, widespread national atten-
tion and media coverage called for revision of 
existing practices, and as a result, a decrease in 
incidence rates has been reported.12
Overdiagnosis was thought to be a problem spe-
cific to developed nations, but with an epidemi-
ologic transition from communicable diseases to 
chronic noninfectious diseases, this phenome-
non could occur in developing countries also. 
Diagnostic laboratories and imaging facilities 
are increasing in India. In fact, Kerala, with its 
high socioeconomic and educational status, has 
health care quality that matches that of a devel-
oped region. This may be the only reasonable 
explanation for why the thyroid cancer incidence 
rate in Kerala is four times that seen in other 
parts of India and why it doubled in a decade.
Why is it important that we identify the reason for 
this phenomenon? A large proportion of patients 
diagnosed with thyroid cancer are women 
younger than 50 years old, and treatment of thy-
roid cancer could result in an increased risk for 
hypertension, heart disease, stroke, nutritional 
deficiencies, and osteoporosis.13 To fulfill the vow 
that we took when we became doctors to do no 
harm, it is imperative that we see the elephant in 
the room for what it is. Overdiagnosis could be 
the most plausible hypothesis for the dramatic 
increase in thyroid cancer in Kerala and several 
other regions in India.
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